Clinical Professor Michaela Lucas is a Clinical Immunologist/Allergist and Immunopathologist and Clinician-Scientist with conjoint appointments with Sir Charles Gairdner Hospital, Pathwest, the Perth Children’s Hospital, and The University of Western Australia, where she leads a multi-disciplinary team of clinical and basic science researchers, microsurgeons and technicians, at the Immunology and Transplantation Lab. After completing medical training in Germany, she received a Marie Curie Research Fellowship and undertook a four-year postdoctoral position at the University of Oxford where she studied liver T-cell immunology. Her research interests and expertise span T cell immunology including the pathogenesis of T cell mediated drug allergies, anti-viral T cell responses, vaccine development, and most recently understanding the role of inflammation in the development of adaptive immunity in organ transplantation. Professor Lucas is also leading a world-first research study investigating the impacts of plastics exposure on human health. This is known as the PERTH Trial - Plastic Exposure Reduction Transforms Health:

https://www.uwa.edu.au/projects/the-perth-trial

Professor Lucas’s research has produced over 150 peer-reviewed papers. She has held multiple national and international research grants as a principal and co-investigator. In addition, Professor Lucas is conducting two investigator-driven randomised controlled trials in antibiotic allergy. She is a leading clinician in the field of Drug Allergy Management in Australia, and is the past President of the Australasian Society of Clinical Immunology and Allergy (ASCIA), co-Director of the National Allergy Council (NAC) and the project lead in Drug Allergy for the National Allergy Strategy and the National Allergy Centre of Excellence (NACE).

https://www.uwa.edu.au/projects/the-perth-trial